Neurodegeneration is a phenomenon that occurs in the central nervous system through the
hallmarks associating the loss of neuronal structure and function. Neurodegeneration is …

Experimental autoimmune encephalomyelitis (EAE) is the most commonly used
experimental model for the human inflammatory demyelinating disease, multiple sclerosis …

The presence of the blood–brain barrier (BBB) restricts the movement of soluble mediators
and leukocytes from the periphery to the central nervous system (CNS). Leukocyte entry into …

The treatment of various central nervous system (CNS) diseases has been challenging,
despite the rapid development of several novel treatment approaches. The blood–brain …

Multiple sclerosis (MS) is an autoimmune disease characterized by recurrent episodes of
demyelination and axonal lesion mediated by CD4+ T cells with a proinflammatory Th1 and …

Neuroinflammation is involved in several neurodegenerative disorders and emerging
evidence indicates that it constitutes a critical process that is required for the progression of …

In the present work, the activated carbon (AC) adsorbent with multimodal pore size
distribution prepared from Amygdalus scoparia as low-cost and locally available source was …

Situated between the circulation and the brain, the blood–brain barrier (BBB) protects the
brain from circulating toxins while securing a specialized environment for neuro-glial …

Bidirectional interactions between the immune and the nervous systems are of considerable
interest both for deciphering their functioning and for designing novel therapeutic strategies …

Neurotransmitters are endogenous chemicals that allow neurons to communicate with each
other throughout the body. They enable the brain to provide a variety of functions, through …